Evaluation of the Hematologic Safety of Same Day Versus Standard Administration (24- to 72-Hour Delay) of Pegfilgrastim in Gynecology Oncology Patients Undergoing Cytotoxic Chemotherapy
Caroline C. Billingsley, Samuel N. Jacobson, Sarah M. Crafton, Aleia K. Crim, Quan Li, Erinn M. Hade, David E. Cohn, Jeffrey M. Fowler, Larry J. Copeland, Ritu Salani, Floor J. Backes, David M. O’Malley
International Journal of Gynecologic Cancer Sep 2015, 25 (7) 1331-1336; DOI: 10.1097/IGC.0000000000000487